☰

Karyn J. Catalano, Ph.D. - Publications

Affiliations: 
2007 Physiology and Biophysics: Doctor of Philosophy University of Southern California, Los Angeles, CA, United States 
Area:
Endocrinology/Metabolism, Diabetes
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kabir M, Iyer MS, Richey JM, Woolcott OO, Asare Bediako I, Wu Q, Kim SP, Stefanovski D, Kolka CM, Hsu IR, Catalano KJ, Chiu JD, Ionut V, Bergman RN. CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors. American Journal of Physiology. Endocrinology and Metabolism. 309: E747-58. PMID 26306598 DOI: 10.1152/Ajpendo.00196.2015  0.825
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets. Plos One. 10: e0131033. PMID 26075612 DOI: 10.1371/journal.pone.0131033  0.811
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets. Plos One. 10: e0123558. PMID 25855974 DOI: 10.1371/Journal.Pone.0123558  0.828
2014 Catalano KJ, Maddux BA, Szary J, Youngren JF, Goldfine ID, Schaufele F. Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain. Plos One. 9: e108693. PMID 25259572 DOI: 10.1371/journal.pone.0108693  0.527
2014 Chiappini F, Catalano KJ, Lee J, Peroni OD, Lynch J, Dhaneshwar AS, Wellenstein K, Sontheimer A, Neel BG, Kahn BB. Ventromedial hypothalamus-specific Ptpn1 deletion exacerbates diet-induced obesity in female mice. The Journal of Clinical Investigation. 124: 3781-92. PMID 25083988 DOI: 10.1172/Jci68585  0.467
2014 Ader M, Stefanovski D, Kim SP, Richey JM, Ionut V, Catalano KJ, Hucking K, Ellmerer M, Van Citters G, Hsu IR, Chiu JD, Woolcott OO, Harrison LN, Zheng D, Lottati M, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring, Md.). 22: 1238-45. PMID 24123967 DOI: 10.1002/Oby.20625  0.797
2012 Kim SP, Woolcott OO, Hsu IR, Stefanoski D, Harrison LN, Zheng D, Lottati M, Kolka C, Catalano KJ, Chiu JD, Kabir M, Ionut V, Bergman RN, Richey JM. CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs. American Journal of Physiology. Endocrinology and Metabolism. 302: E1261-8. PMID 22374758 DOI: 10.1152/Ajpendo.00496.2011  0.835
2012 Woolcott OO, Bergman RN, Richey JM, Kirkman EL, Harrison LN, Ionut V, Lottati M, Zheng D, Hsu IR, Stefanovski D, Kabir M, Kim SP, Catalano KJ, Chiu JD, Chow RH. Simplified method to isolate highly pure canine pancreatic islets. Pancreas. 41: 31-8. PMID 21792087 DOI: 10.1097/Mpa.0B013E318221Fd0E  0.755
2011 Kabir M, Stefanovski D, Hsu IR, Iyer M, Woolcott OO, Zheng D, Catalano KJ, Chiu JD, Kim SP, Harrison LN, Ionut V, Lottati M, Bergman RN, Richey JM. Large size cells in the visceral adipose depot predict insulin resistance in the canine model. Obesity (Silver Spring, Md.). 19: 2121-9. PMID 21836643 DOI: 10.1038/Oby.2011.254  0.815
2010 Catalano KJ, Stefanovski D, Bergman RN. Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Diabetes. 59: 1416-23. PMID 20299478 DOI: 10.2337/Db08-0675  0.788
2009 Richey JM, Woolcott OO, Stefanovski D, Harrison LN, Zheng D, Lottati M, Hsu IR, Kim SP, Kabir M, Catalano KJ, Chiu JD, Ionut V, Kolka C, Mooradian V, Bergman RN. Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs. American Journal of Physiology. Endocrinology and Metabolism. 296: E1311-8. PMID 19366874 DOI: 10.1152/Ajpendo.90972.2008  0.757
2007 Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. The American Journal of Medicine. 120: S3-8; discussion S29. PMID 17296343 DOI: 10.1016/J.Amjmed.2006.11.012  0.852
2007 Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. American Journal of Physiology. Endocrinology and Metabolism. 292: E1590-8. PMID 17264230 DOI: 10.1152/Ajpendo.00669.2006  0.866
2007 Harrison LN, Stefanovski D, Woolcott O, Lottati M, Zheng D, Ionut V, Kim SP, Hsu I, Kabir M, Catalano KJ, Chiu JD, Bergman RN, Richey JM. Cannabinoid receptor antagonist rimonabant prevents weight gain in dogs on a high fat diet The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A694-D  0.752
2006 Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring, Md.). 14: 16S-19S. PMID 16642958 DOI: 10.1038/Oby.2006.277  0.844
2005 Catalano KJ, Bergman RN, Ader M. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats. Obesity Research. 13: 11-20. PMID 15761159 DOI: 10.1038/Oby.2005.4  0.673
2005 Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 54: 862-71. PMID 15734866 DOI: 10.2337/Diabetes.54.3.862  0.839
2005 Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. American Journal of Physiology. Endocrinology and Metabolism. 288: E454-61. PMID 15522994 DOI: 10.1152/Ajpendo.00203.2004  0.869
2003 Ader M, Kim S, Catalano K, Ionut V, Hucking K, Richey J, Kabir M, Bergman R. P.2.093 Marked increase in adiposity during olanzapine vs risperidone treatment: Results of a placebo-controlled study in normal dogs European Neuropsychopharmacology. 13: S320-S321. DOI: 10.1016/S0924-977X(03)92046-3  0.734
Show low-probability matches.